Page last updated: 2024-08-18

framycetin and Myelodysplastic Syndromes

framycetin has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brenner, MK; Heslop, HE; Krance, RA; Moen, R; Roberts, WM; Rochester, R; Rooney, C; Sixbey, J; Smith, CA; Turner, V	1

Trials

1 trial(s) available for framycetin and Myelodysplastic Syndromes

Article	Year
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Human gene therapy, 1994, Volume: 5, Issue:3 Topics: Adult; Biomarkers; Bone Marrow Transplantation; Cell Line; Child; Clinical Protocols; Cytotoxicity, Immunologic; Drug Resistance; Female; Genetic Vectors; Graft vs Host Disease; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Incidence; Informed Consent; Kanamycin Kinase; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Moloney murine leukemia virus; Myelodysplastic Syndromes; Neomycin; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Safety; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous; Tumor Virus Infections; Virus Activation	1994

Article

Year

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.

Human gene therapy, 1994, Volume: 5, Issue:3

Topics: Adult; Biomarkers; Bone Marrow Transplantation; Cell Line; Child; Clinical Protocols; Cytotoxicity, Immunologic; Drug Resistance; Female; Genetic Vectors; Graft vs Host Disease; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Incidence; Informed Consent; Kanamycin Kinase; Leukemia; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Moloney murine leukemia virus; Myelodysplastic Syndromes; Neomycin; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins; Safety; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous; Tumor Virus Infections; Virus Activation

1994